Editorial: How should the dose of iodine-131 be determined in the treatment of graves' hyperthyroidism?

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 3, 2003, Pages 975-977

  Kalinyak, Judith E ^a   McDougall, I Ross ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; RADIOACTIVE IODINE;

CANCER RADIOTHERAPY; DOSE CALCULATION; DRUG DETERMINATION; DRUG UPTAKE; EDITORIAL; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; PRESCRIPTION; PRIORITY JOURNAL; RADIATION ABSORPTION; STIMULUS RESPONSE; THYROID FUNCTION; NOTE; RADIATION DOSE;

GRAVES DISEASE; HUMANS; IODINE RADIOISOTOPES; RADIOTHERAPY DOSAGE;

EID: 0037364219     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021801     Document Type: Editorial

References (24)

1. Hertz S, Roberts A 1942 Application of radioactive iodine in therapy of Graves' disease. J Clin Invest 21:624 (Abstract)
2. Hamilton JG, Lawrence HH 1942 Recent clinical developments in the therapeutic application of radiophosphorus and radio-iodine. J Clin Invest 21:624 (Abstract)
3. Chapman EM 1983 History of the discovery and early use of radioactive iodine. JAMA 250:2042-2044
4. Sawin CT, Becker DV 1997 Radioiodine and the treatment of hyperthyroidism: the early history. Thyroid 7:163-176
5. Ron E, Doody MM, Becker DV, Brill AB, Curtis RE, Goldman MB, Harris III BS, Hoffman DA, McConahey WM, Maxon HR, Preston-Martin S, Warshauer ME, Wong FL, Boice Jr JD 1998 Cancer mortality following treatment for adult hyperthyroidism: Cooperative Thyrotoxicosis Follow-up Study Group. JAMA 280:347-355
6. Leslie WD, Ward L, Salamon EA, Ludwig S, Rowe RC, Cowden EA 2003 A randomized comparison of radioiodine dose in Graves' hyperthyroidism. J Clin Endocrinol Metab 88:0000-0000
7. 131I therapy. Br Med J 1:151-154
8. Tuttle RM, Patience T, Budd S 1995 Treatment with propylthiouracil before radioactive iodine is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease. Thyroid 5:243-247
9. Imseis RE, Van Middlesworth L, Massie JD, Bush AJ, Van Middlesworth NR 1998 Pretreatment with propylthiouracil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism. J Clin Endocrinol Metab 83:685-687
10. 131I treatment of hyperthyroidism. Ann Intern Med 76:721-723
11. 131I therapy of thyrotoxicosis (diffuse goiters). N Engl J Med 290:141-143
12. 131I therapy for Graves' disease. N Engl J Med 31:426-432
13. Moser E, Pickardt CR, Mann K, Engelhardt D, Kitsch CM, Knesewitsch P, Tatsch K, Kreisig T, Kurz C, Saller B 1988 Results with radioiodine therapy of patients with immunogenic and non-immunogenic hyperthyroidism using different radiation doses. Nuklearmedizin 27:98-104
14. Howarth D, Epstein M, Lan L, Tan P, Booker J 2001 Determination of the optimal minimum radioiodine dose in patients with Graves' disease: a clinical outcome study. Eur J Nucl Med 28:1489-1495
15. Guhlmann CA, Rendl J, Borner W 1995 Radioiodine therapy of autonomously functioning thyroid nodules and Graves' disease. Nuklearmedizin 34:20-23
16. Willemsen UF, Knesewitsch P, Kreisig T, Pickard CR, Kitsch CM 1993 Functional results of radioiodine therapy with a 300 Gy absorbed dose in Graves' disease. Eur J Nucl Med 20:1051-1055
17. Reinhardt MJ, Brink I, Joe AY, Von Mallek D, Ezziddin S, Palmedo H, Krause TM 2002 Radioiodine therapy in Graves' disease based on tissue-absorbed calculations: effect of pre-treatment thyroid volume on clinical outcome. Eur J Nucl Med Mol Imaging 29:1118-24
18. Chen JJS, LaFrance N, Allo MD, Cooper DS, Ladenson PW 1988 Single photon emission computed tomography of the thyroid. J Clin Endocrinol Metab 66:1240-1246
19. Schlogl S, Werner E, Lassmann M, Terekhova J, Muffert S, Seybold S, Reiners C 2001 The use of three-dimensional ultrasound for thyroid volumetry. Thyroid 11:569-574
20. Cunnien AJ, Hay ID, Gorman CA, Offord KP, Scanlon PW 1982 Radioiodine-induced hypothyroidism in Graves' disease: factors associated with the increasing incidence. J Nucl Med 23:978-983
21. Van Isselt JW, de Klerk JMH, Koppeschaar HPF, Van Rijk PP 2000 Iodine-131 uptake and turnover rate vary over short intervals in Graves' disease. Nucl Med Commun 21:609-616
22. Al-Kaabi JM, Hussein SS, Bukheit CS, Woodhouse NJ, Elshafie OT, Bererhi H 2002 Radioactive iodine in the treatment of Graves' disease. Saudi Med J 23:1049-1053
23. Scott GR, Forfar JC, Toft AD 1984 Graves' disease and atrial fibrillation: the case for even higher doses of therapeutic iodine-131. Br Med J 289:399-400
24. McDougall IR 1990 The importance of obtaining thyroid uptake measurement in patients with hyperthyroidism. Nucl Med Commun 11:73-76